Kevin J. Heyeck

Kevin Heyeck is a seasoned biopharmaceutical business development executive with 20 years experience in life sciences, including Sr. leadership roles with multiple emerging companies and an extensive worldwide deal sheet. Currently Mr. Heyeck is an independent consultant providing strategic and business development leadership to early stage life science companies. Previously, he was Chief Business Officer of AlloCure, a venture backed, development stage biopharmaceutical company developing innovative products for kidney disease. At AlloCure, he led the effort to secure a their $25M Series B round from venture investors. Prior to joining AlloCure, Mr. Heyeck was Vice President, Business Development at Vitae Pharmaceuticals, where he headed Vitae’s business development activities and was responsible for securing multiple major partnerships, generating $100M in non-contingent capital. Prior to Vitae, Mr. Heyeck headed Business Development for Pharmacopeia, a company that was a pioneer in the use of combinatorial chemistry in drug discovery. While there he was responsible for numerous partnerships with large pharmaceutical and biotechnology companies worldwide. Prior to Pharmacopeia, Mr. Heyeck was Technology Transfer Officer at Harvard University. He received his B.A. in Politics at the University of California, Santa Cruz.